Effects of dobutamine on ischemic vasodilation of the forearm in patients with severe congestive heart failure

Journal of Cardiac Failure

Volumn 5, Issue 1, 1999, Pages 25-30

  Delehanty, Joseph ^a   Liang, Chang Seng ^a   Odorisi, Marc L ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Catecholamines; Heart failure; Peripheral circulation; Reactive hyperemia

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FOREARM BLOOD FLOW; HEART HEMODYNAMICS; HEART LEFT VENTRICLE PERFORMANCE; HUMAN; HYPEREMIA; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; PRIORITY JOURNAL; VASCULAR RESISTANCE;

EID: 0032980071     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(99)90021-0     Document Type: Article

References (22)

1. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN: Activity of the sympathetic nervous system and reninangiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982;49:1659-66
2. Leithe ME, Magorien RD, Hermiller JB, Unverferth DV, Leier CV: Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 1984;69:57-64
3. Zelis R, Mason DT, Braunwald E: A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 1968;47:960-70
4. Leier CV, Heban PT, Huss P, Bush CA, Lewis RP: Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 1978;58:466-75
5. Zelis R, Longhurst J, Capone RJ, Mason DT: A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation 1974;50:137-43
6. Pouleur H, Marechal O, Balasini H, Van Mechelan H, Ries A, Rousseau MF, Charlier AA: Effects of dobutamine and sulmazol (AR-L115 BS) on myocardial metabolism and coronary, femoral and renal blood flows: a comparative study in normal dogs and in dogs with chronic overload. J Cardiovasc Pharmacol 1983;5:861-7
7. Katz SD, Schwarz M, Yuen J, LeJemtel TH: Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 1993;88: 55-61
8. Katz SD, Krum H, Than T, Knecht M: Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol 1996;28:585-90
9. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM: Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96
10. Schwarz M, Katz SD, Demopoulos L, Hirsch H, Yuen JL, Jondeau O, LeJemtel TH: Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure. Circulation 1994;89: 1609-14
11. Katz SD: Mechanisms and implications of endothelial dysfunction in congestive heart failure. Curr Opin Cardiol 1997;12:259-64
12. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A: Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994;90:2285-90
13. Hirooka Y, Imaizumi T, Tagawa T, Shiramoto M, Endo T, Ando S, Takeshita A: Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994;90: 658-68
14. Liang CS, Thomas A, Imai N, Stone CK, Kawashima S, Hood WB Jr: Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine. J Cardiovasc Pharmacol 1987;10:509-16
15. Mancini DM, Schwartz M, Ferraro N, Seestedt R, Chance B, Wilson, JR: Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 1990;65:1121-6
16. Khan T, Levin HR, Oz MC, Katz SD: Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device. J Heart Lung Transplant 1997;16:449-53
17. Graves J, Poston L: β-Adrenoceptor agonist-mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br J Pharmacol 1993;108: 631-7
18. Dawes M, Chowienczyk PJ, Ritter JM: Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by β-adrenergic agonists in human forearm. Circulation 1997;95:2293-7
19. Rebich S, Devine JO, Armstead WM: Role of nitric acid and cAMP in β-adrenoceptor-induced pial artery vasodilation. Am J Physiol 1995;268:H1071-6
20. Chang H: Role of nitric oxide in vasodilator response induced by salbutamol in rat diaphragmatic microcirculation. Am J Physiol 1997;272:H2173-9
21. Kraemer MD, Kubo SH, Rector TS, Brunsvold N, Bank AJ: Pulmonary and peripheral vascular factors are important determinants of risk exercise uptake in patients with heart failure. J Am Coll Cardiol 1993;21:641-8
22. Liang C-S, Sherman LG, Doherty JU, Wellington K, Lee VW, Hood WB Jr: Sustained improvement of cardiac function in congestive heart failure after short-term infusion of dobutamine. Circulation 1984;69:113-9